Sequential is proud to announce the launch of the industry's first-ever target panels, designed to address key skin concerns. These panels are the first of their kind, resulting from years of meticulous research by our scientists who have worked tirelessly to uncover the underlying microbial factors driving these conditions.
 
Contrary to more traditional methods of studying the microbiome, Sequential’s panels offer a uniquely targeted approach, allowing clients to focus their research on specific areas of interest. Backed by a robust database of over 20,000 microbial samples and numerous studies, we are excited to bring this groundbreaking tool to our clients, paving the way for new insights and innovations in skincare.